Form 3 Filing for Margaret Smith
2026-08-17SEC Filing 3 (0002149973-26-000002)
This filing is a Form 3, which reports initial beneficial ownership of securities. Margaret Smith, the Chief Commercial Officer of ARS Pharmaceuticals, Inc., has appointed Richard Lowenthal, Kathleen Scott, and Justin Chakma as her attorneys-in-fact to execute and file Forms 3, 4, and 5 on her behalf. This Power of Attorney remains in effect until Smith is no longer required to file these forms, she revokes it in writing, or the appointed attorneys-in-fact are no longer employed by the Company. The filing indicates Smith owns one security, though the specifics are not detailed in this document.
Ticker mentioned:SPRY
Source:Original SEC Document β